Aug 28, 2026 06:25AM
Aug 28, 2026 06:00AM
May 28, 2026 07:00AM
May 28, 2026 07:00AM
May 15, 2026 07:00AM
Apr 17, 2026 07:01AM
Apr 17, 2026 07:00AM BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
Apr 2, 2026 06:43AM
Apr 1, 2026 07:03AM
Apr 1, 2026 07:01AM
Apr 1, 2026 07:00AM
Apr 1, 2026 07:00AM
Feb 14, 2024 08:30AM
Mar 10, 2022 04:28PM Truist Securities Reiterates BioXcel Therapeutics (BTAI) at Buy Ahead of April 5th PDUFA, Analysts Expects Approval and Sees Company Well Prepared for Commercial Launch
Mar 10, 2022 07:04AM
Feb 22, 2022 11:05AM
Feb 22, 2022 11:05AM
Dec 1, 2021 11:05AM
Dec 1, 2021 09:19AM
Dec 1, 2021 08:38AM
Dec 1, 2021 07:06AM BioXcel Therapeutics (BTAI) Announces Extension of FDA Review Period of its NDA for BXCL501 for the Acute Treatment of Agitation Associated with Schizophrenia and Bipolar Disorders
Dec 1, 2021 07:00AM
Nov 10, 2021 07:00AM
Aug 10, 2021 07:00AM
Jun 23, 2021 07:17AM
May 19, 2021 07:02AM
May 19, 2021 07:00AM
Feb 20, 2020 09:19AM Pre-Open Stock Movers 02/20: (IOTS) (STMP) (ETFC) Higher (TVTY) (SIX) (OSUR) Lower (more...)

15,739 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All